Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments is a research paper published in Frontiers in Pharmacology (2021). On theSindex it has a DataRank of 0.677. It has been cited 90 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.677
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institute of Neurological Disorders and Stroke
Grant: R21-NS091555 R37NS094804 R01NS074387 R01NS076991 R01NS082311 R01NS096756
National Institute of Biomedical Imaging and Bioengineering
Grant: R01-EB022563
National Cancer Institute
Grant: T32- CA009676
NINDS NIH HHS
Grant: R01 NS096756
NIBIB NIH HHS
Grant: R01 EB022563
NINDS NIH HHS
Grant: R37 NS094804
NCI NIH HHS
Grant: T32 CA009676
National Institutes of Health
Grant: 1R01NS082311-01
Mechanisms of glioma growth and invasion novel therapeutic strategies
National Institutes of Health
Grant: 1R01NS096756-01
Neuroimmunology of Malignant Brain Tumors: Innate Mechanisms
National Institutes of Health
Grant: 7R01NS074387-02
Crosstalk between glioma cells & immune cells in the tumor microenvironment: Ther
National Institutes of Health
Grant: 5R01EB022563-04
Tuning Biomaterials-immune cell interactions for treatment of glioblastoma multiforme
National Institutes of Health
Grant: 5R01NS076991-07
Novel Gene Therapy Strategies for Canavan Disease
National Institutes of Health
Grant: 1T32CA009676-01A1
CANCER BIOLOGY TRAINING PROGRAM
National Institutes of Health
Grant: 1R21NS091555-01
HDL-Loaded Nanoparticles for Glioma Therapeutics
National Institutes of Health
Grant: 5R37NS094804-06
Immune-suppressive Myeloid Cells in the Glioma Microenvironment: Signaling Mechanisms and Novel Therapeutic Strategies
FWCI
5.12
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals